This company has been acquired
Ocean Bio-Chem Management
Management criteria checks 4/4
Key information
Peter Dornau
Chief executive officer
US$356.6k
Total compensation
| CEO salary percentage | 62.39% |
| CEO tenure | 49.6yrs |
| CEO ownership | 2.8% |
| Management average tenure | 16.9yrs |
| Board average tenure | 15yrs |
Recent management updates
This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)
We'd be surprised if Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) shareholders haven't noticed that the Executive VP of Sales...Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been Selling
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO Salary
Peter Dornau has been the CEO of Ocean Bio-Chem, Inc. (NASDAQ:OBCI) since 1973, and this article will examine the...Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | US$5m |
| Mar 31 2022 | n/a | n/a | US$8m |
| Dec 31 2021 | US$357k | US$222k | US$8m |
| Sep 30 2021 | n/a | n/a | US$9m |
| Jun 30 2021 | n/a | n/a | US$10m |
| Mar 31 2021 | n/a | n/a | US$11m |
| Dec 31 2020 | US$319k | US$208k | US$10m |
| Sep 30 2020 | n/a | n/a | US$9m |
| Jun 30 2020 | n/a | n/a | US$6m |
| Mar 31 2020 | n/a | n/a | US$3m |
| Dec 31 2019 | US$294k | US$200k | US$3m |
| Sep 30 2019 | n/a | n/a | US$3m |
| Jun 30 2019 | n/a | n/a | US$3m |
| Mar 31 2019 | n/a | n/a | US$3m |
| Dec 31 2018 | US$312k | US$195k | US$3m |
| Sep 30 2018 | n/a | n/a | US$3m |
| Jun 30 2018 | n/a | n/a | US$3m |
| Mar 31 2018 | n/a | n/a | US$3m |
| Dec 31 2017 | US$300k | US$183k | US$3m |
| Sep 30 2017 | n/a | n/a | US$3m |
| Jun 30 2017 | n/a | n/a | US$3m |
| Mar 31 2017 | n/a | n/a | US$3m |
| Dec 31 2016 | US$260k | US$171k | US$2m |
| Sep 30 2016 | n/a | n/a | US$2m |
| Jun 30 2016 | n/a | n/a | US$479k |
| Mar 31 2016 | n/a | n/a | -US$64k |
| Dec 31 2015 | US$210k | US$161k | US$461k |
Compensation vs Market: Peter's total compensation ($USD356.57K) is below average for companies of similar size in the US market ($USD770.24K).
Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.
CEO
Peter Dornau (82 yo)
Mr. Peter G. Dornau co-founded Ocean Bio-Chem Inc. and has been its Chief Executive Officer, President, Chairman and Director since 1973.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 49.6yrs | US$356.57k | 2.79% $ 3.5m | |
| CFO, VP of Finance & Director | 15.4yrs | US$302.48k | 1.89% $ 2.3m | |
| COO, VP | 18.3yrs | US$305.11k | 2.7% $ 3.3m | |
| Executive VP of Sales & Marketing and Director | 15yrs | US$388.43k | 4.8% $ 6.0m | |
| Controller of Financial Reporting | no data | no data | no data |
Experienced Management: OBCI's management team is seasoned and experienced (16.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 49.6yrs | US$356.57k | 2.79% $ 3.5m | |
| CFO, VP of Finance & Director | 15yrs | US$302.48k | 1.89% $ 2.3m | |
| COO, VP | 15yrs | US$305.11k | 2.7% $ 3.3m | |
| Executive VP of Sales & Marketing and Director | 15yrs | US$388.43k | 4.8% $ 6.0m | |
| Director | 24.3yrs | US$14.95k | 0.76% $ 941.6k | |
| Independent Director | 22.2yrs | US$17.75k | 0.84% $ 1.0m | |
| Independent Director | 11.3yrs | US$17.75k | 0.063% $ 77.8k | |
| Independent Director | 6.1yrs | US$17.75k | 0.053% $ 65.2k |
Experienced Board: OBCI's board of directors are seasoned and experienced ( 15 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/08/09 16:04 |
| End of Day Share Price | 2022/08/08 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ocean Bio-Chem, Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.